血液透析患者中内皮相关生物标志物、高磷血症与死亡率：一项调节分析 - Suppr

Endothelium-related biomarkers, hyperphosphatemia and mortality in hemodialysis patients: a moderation analysis.

作者信息

Fujiike Dennis Tomio, Santos Leticia Libório, Silveira de Andrade Luana, Meneses Gdayllon Cavalcante, Martins Alice Maria Costa, Libório Alexandre Braga

机构信息

Medical Program, Universidade de Fortaleza- UNIFOR, Fortaleza, Ceará, Brazil.

Medical Sciences Postgraduate Program, Department of Internal Medicine, Medical School, Federal University of Ceará, Fortaleza, Brazil.

出版信息

J Nephrol. 2024 Sep;37(7):2039-2041. doi: 10.1007/s40620-024-02033-3. Epub 2024 Jul 31.

DOI:10.1007/s40620-024-02033-3

PMID:39085573

Abstract

摘要

相似文献

J Nephrol. 2024 Sep;37(7):2039-2041. doi: 10.1007/s40620-024-02033-3. Epub 2024 Jul 31.

Mild hyperphosphatemia and mortality in hemodialysis patients.血液透析患者的轻度高磷血症与死亡率

Am J Kidney Dis. 2005 Jul;46(1):68-77. doi: 10.1053/j.ajkd.2005.04.006.

Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients.高血压血液透析患者的高磷血症及其与血压、血管收缩和内皮细胞功能障碍的关系。

BMC Nephrol. 2022 Aug 23;23(1):291. doi: 10.1186/s12882-022-02918-0.

Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.PA21对日本高磷血症血液透析患者的剂量反应疗效及安全性：一项随机、安慰剂对照、双盲的II期研究。

Clin Exp Nephrol. 2017 Jun;21(3):513-522. doi: 10.1007/s10157-016-1299-z. Epub 2016 Jul 7.

Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials.碳酸镧对维持性血液透析患者全因死亡率的影响：一项随机对照试验的荟萃分析

Kidney Blood Press Res. 2018;43(2):536-544. doi: 10.1159/000488700. Epub 2018 Mar 29.

Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.营养师参与由透析工作人员主导的血液透析患者高磷血症控制饮食教育的额外益处。

Clin Exp Nephrol. 2016 Oct;20(5):815-821. doi: 10.1007/s10157-015-1212-1. Epub 2015 Dec 11.

Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.强化教育方案在血液透析患者磷控制中的实施和效果：一项非随机、单臂、单中心试验。

BMC Nephrol. 2021 Jul 1;22(1):243. doi: 10.1186/s12882-021-02441-8.

Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis.饮食教育干预对血液透析患者高磷血症管理的效果：系统评价和荟萃分析。

Nutr Rev. 2014 Jul;72(7):471-82. doi: 10.1111/nure.12115. Epub 2014 Jun 11.

Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.镁可改变血液透析患者高磷血症相关的心血管死亡风险：一项队列研究。

PLoS One. 2014 Dec 29;9(12):e116273. doi: 10.1371/journal.pone.0116273. eCollection 2014.

Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients.联合碱性磷酸酶和磷水平作为维持性血液透析患者死亡率的预测指标

Medicine (Baltimore). 2014 Oct;93(18):e106. doi: 10.1097/MD.0000000000000106.

本文引用的文献

Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort.矿物质和骨生物标志物与德国慢性肾脏病（GCKD）队列不良心血管结局和死亡的关联。

Bone Res. 2023 Oct 20;11(1):52. doi: 10.1038/s41413-023-00291-8.

Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients.血清磷酸盐与透析患者他汀类药物治疗疗效的关系。

Clin J Am Soc Nephrol. 2022 Apr;17(4):546-554. doi: 10.2215/CJN.12620921. Epub 2022 Mar 2.

Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans.慢性肾脏病中的高磷血症通过甘露糖苷酶介导的 SCAP N-聚糖复合物类型转换加剧动脉粥样硬化。

Kidney Int. 2021 Jun;99(6):1342-1353. doi: 10.1016/j.kint.2021.01.016. Epub 2021 Feb 23.

Cognitive impairment, endothelial biomarkers and mortality in maintenance haemodialysis patients: a prospective cohort study.认知障碍、内皮生物标志物与维持性血液透析患者的死亡率：一项前瞻性队列研究。

Nephrol Dial Transplant. 2020 Oct 1;35(10):1779-1785. doi: 10.1093/ndt/gfaa040.

Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.高磷血症时血管平滑肌细胞钙化相关的信号通路。

Cell Mol Life Sci. 2019 Jun;76(11):2077-2091. doi: 10.1007/s00018-019-03054-z. Epub 2019 Mar 18.

A role for the endothelium in vascular calcification.内皮在血管钙化中的作用。

Circ Res. 2013 Aug 16;113(5):495-504. doi: 10.1161/CIRCRESAHA.113.301792. Epub 2013 Jul 12.

Mild hyperphosphatemia and mortality in hemodialysis patients.血液透析患者的轻度高磷血症与死亡率

Am J Kidney Dis. 2005 Jul;46(1):68-77. doi: 10.1053/j.ajkd.2005.04.006.

New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study.用于对腹主动脉钙化病变的位置、严重程度和进展进行分类的新指标：一项25年的随访研究。

Atherosclerosis. 1997 Jul 25;132(2):245-50. doi: 10.1016/s0021-9150(97)00106-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Endothelium-related biomarkers, hyperphosphatemia and mortality in hemodialysis patients: a moderation analysis.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献